Clinical Outcomes of Pola-R-CHP Therapy in Patients Aged >80 Years With Diffuse Large B-Cell Lymphoma
Anticancer Research · 2026-07 · 46 (7) · 4045-4054
DOI: 10.21873/anticanres.18264 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, online erschienen am 29.06.2026. Verfasst von Yuta Baba und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Department of Medicine, Showa Medical University Fujigaoka Hospital, Kanagawa, Japan y.baba26@med.showa-u.ac.jp. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology, Department of Medicine, Showa Medical University Fujigaoka Hospital, Kanagawa, Japan y.baba26@med.showa-u.ac.jp.
- Division of Hematology, Department of Medicine, Showa Medical University Fujigaoka Hospital, Kanagawa, Japan.
Zitieren
APA
Baba, Y., Fukumura, S., Tanai, S., Maeda, N., Shimada, Y., Abe, M., Kabasawa, N., Sakai, H., & Fukuda, T. (2026). Clinical Outcomes of Pola-R-CHP Therapy in Patients Aged >80 Years With Diffuse Large B-Cell Lymphoma. Anticancer Research, 46(7), 4045-4054. https://doi.org/10.21873/anticanres.18264
Vancouver
Baba Y, Fukumura S, Tanai S, Maeda N, Shimada Y, Abe M, et al. Clinical Outcomes of Pola-R-CHP Therapy in Patients Aged >80 Years With Diffuse Large B-Cell Lymphoma. Anticancer Research. 2026;46(7):4045-4054. doi:10.21873/anticanres.18264
BibTeX
@article{Baba2026,
author = {Baba, Yuta and Fukumura, Satoshi and Tanai, Seira and Maeda, Nodoka and Shimada, Yuka and Abe, Maasa and Kabasawa, Nobuyuki and Sakai, Hirotaka and Fukuda, Tetsuya},
title = {Clinical Outcomes of Pola-R-CHP Therapy in Patients Aged >80 Years With Diffuse Large B-Cell Lymphoma},
journal = {Anticancer Research},
year = {2026},
volume = {46},
number = {7},
pages = {4045--4054},
doi = {10.21873/anticanres.18264}
}
EUVIMED